Sven Borchmann

机构：University of Cologne, Düsseldorf University Hospital, Integrated Oncology (United States), German Inflammatory Bowel Diseases Study Group, University Hospital Cologne, Heinrich Heine University Düsseldorf · ORCID：0000-0001-6662-6864

发表论文 112 篇 · 总被引 1899 次 · h-index 24

代表论文

• Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial (2024 · The Lancet · 被引 140)
• Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma (2024 · Journal of Clinical Oncology · 被引 46)
• Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA (2023 · Blood · 被引 41)
• Sex differences in the pharmacokinetics of anticancer drugs: a systematic review (2024 · ESMO Open · 被引 40)
• CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma (2025 · Cancer Cell · 被引 27)
• Correlation between progression-free and overall survival in patients with Hodgkin lymphoma: a comprehensive analysis of individual patient data from randomized German Hodgkin Study Group (GHSG) trials (2024 · Annals of Oncology · 被引 17)